OPEP Device Market Projected to Reach $3.86 Billion by 2031
The market for Oscillating Positive Expiratory Pressure (OPEP) devices used for airway clearance is projected to reach $3.86 billion by 2031, with a compound annual growth rate of 5.26% from 2026 to 2031.
The global market for Oscillating Positive Expiratory Pressure (OPEP) devices, used to aid in clearing airways, is forecast to grow to $3.86 billion by 2031. This represents a compound annual growth rate of 5.26% during the forecast period of 2026 to 2031.
The market expansion is attributed to increasing rates of chronic respiratory diseases such as COPD and asthma, coupled with an aging global population. Technological advancements, including gravity-independent designs and digital connectivity for adherence monitoring, are also key drivers.
In 2025, mouthpiece devices held the largest market share by product type at 44.88%. COPD and asthma were the dominant indications, accounting for 55.01% of the market. Hospitals and clinics were the primary end-users, representing 45.67%, though homecare settings are experiencing rapid growth.
North America led the market in 2025 with a 38.05% revenue share. However, the Asia-Pacific region is expected to exhibit the fastest growth, with an anticipated CAGR of 8.27% through 2031.